Sign Up to like & get
recommendations!
0
Published in 2018 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.12883
Abstract: To evaluate the efficacy, safety, and tolerability of perampanel, a selective, non‐competitive, α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor antagonist, as an adjunctive treatment for patients with refractory partial‐onset seizures (POS) from Asia‐Pacific.
read more here.
Keywords:
asia pacific;
adjunctive perampanel;
partial onset;
onset seizures ... See more keywords